Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edward C F Wilson

Showing results (61-70 of 71) with videos related to

Pageof 8
Sort By:
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|April 12, 2021
Content of Health Economics Analysis Plans (HEAPs) for Trial-Based Economic Evaluations: Expert Delphi Consensus SurveyJoanna C Thorn, Charlotte F Davies, Sara T Brookes, et al.
Trials|October 15, 2025
A pragmatic, randomised, open-label, multi-centre UK registry-facilitated trial evaluating the effect of high-dose cholecalciferol on mortality in patients on dialysis: the SIMPLIFIED trialToby J L Humphrey, Fergus J Caskey, David C Wheeler, et al.
Plos Medicine|July 24, 2020
Effectiveness and cost-effectiveness of the GoActive intervention to increase physical activity among UK adolescents: A cluster randomised controlled trialKirsten Corder, Stephen J Sharp, Stephanie T Jong, et al.
Plos Medicine|March 7, 2020
Evaluation of a very brief pedometer-based physical activity intervention delivered in NHS Health Checks in England: The VBI randomised controlled trialWendy Hardeman, Joanna Mitchell, Sally Pears, et al.
Pharmacoeconomics|June 17, 2010
Cost effectiveness of leukotriene receptor antagonists versus inhaled corticosteroids for initial asthma controller therapy: a pragmatic trialEdward C F Wilson, Erika J Sims, Stanley D Musgrave, et al.
Pharmacoeconomics|May 8, 2010
Cost effectiveness of leukotriene receptor antagonists versus long-acting beta-2 agonists as add-on therapy to inhaled corticosteroids for asthma: a pragmatic trialEdward C F Wilson, David Price, Stanley D Musgrave, et al.
The New England Journal of Medicine|May 6, 2011
Leukotriene antagonists as first-line or add-on asthma-controller therapyDavid Price, Stanley D Musgrave, Lee Shepstone, et al.
Health Technology Assessment (Winchester, England)|June 2, 2025
Clinical and cost-effectiveness of detailed anomaly ultrasound screening in the first trimester: a mixed-methods studyJehan N Karim, Helen Campbell, Pranav Pandya, et al.
Trials|November 8, 2018
DELTA<sup>2</sup> guidance on choosing the target difference and undertaking and reporting the sample size calculation for a randomised controlled trialJonathan A Cook, Steven A Julious, William Sones, et al.
BMJ (Clinical Research Ed.)|December 19, 2018
DELTA<sup>2</sup> guidance on choosing the target difference and undertaking and reporting the sample size calculation for a randomised controlled trialJonathan A Cook, Steven A Julious, William Sones, et al.
Pageof 8

Showing results (61-70 of 71) with videos related to

Sort By:
Pageof 8
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|April 12, 2021
Content of Health Economics Analysis Plans (HEAPs) for Trial-Based Economic Evaluations: Expert Delphi Consensus SurveyJoanna C Thorn, Charlotte F Davies, Sara T Brookes, et al.
Trials|October 15, 2025
A pragmatic, randomised, open-label, multi-centre UK registry-facilitated trial evaluating the effect of high-dose cholecalciferol on mortality in patients on dialysis: the SIMPLIFIED trialToby J L Humphrey, Fergus J Caskey, David C Wheeler, et al.
Plos Medicine|July 24, 2020
Effectiveness and cost-effectiveness of the GoActive intervention to increase physical activity among UK adolescents: A cluster randomised controlled trialKirsten Corder, Stephen J Sharp, Stephanie T Jong, et al.
Plos Medicine|March 7, 2020
Evaluation of a very brief pedometer-based physical activity intervention delivered in NHS Health Checks in England: The VBI randomised controlled trialWendy Hardeman, Joanna Mitchell, Sally Pears, et al.
Pharmacoeconomics|June 17, 2010
Cost effectiveness of leukotriene receptor antagonists versus inhaled corticosteroids for initial asthma controller therapy: a pragmatic trialEdward C F Wilson, Erika J Sims, Stanley D Musgrave, et al.
Pharmacoeconomics|May 8, 2010
Cost effectiveness of leukotriene receptor antagonists versus long-acting beta-2 agonists as add-on therapy to inhaled corticosteroids for asthma: a pragmatic trialEdward C F Wilson, David Price, Stanley D Musgrave, et al.
The New England Journal of Medicine|May 6, 2011
Leukotriene antagonists as first-line or add-on asthma-controller therapyDavid Price, Stanley D Musgrave, Lee Shepstone, et al.
Health Technology Assessment (Winchester, England)|June 2, 2025
Clinical and cost-effectiveness of detailed anomaly ultrasound screening in the first trimester: a mixed-methods studyJehan N Karim, Helen Campbell, Pranav Pandya, et al.
Trials|November 8, 2018
DELTA<sup>2</sup> guidance on choosing the target difference and undertaking and reporting the sample size calculation for a randomised controlled trialJonathan A Cook, Steven A Julious, William Sones, et al.
BMJ (Clinical Research Ed.)|December 19, 2018
DELTA<sup>2</sup> guidance on choosing the target difference and undertaking and reporting the sample size calculation for a randomised controlled trialJonathan A Cook, Steven A Julious, William Sones, et al.
Pageof 8